EUVIMEDEUVIMED entdecken
Crossref

Medical Nutrition Therapy & Metformin in Early Gestational Glucose Intolerance to Prevent Post-Partum Diabetes Risk in a hospital Prospective Study

Shweta Verma, Renu Gupta, Neena Gupta, Divya Dwivedi, Palak Taneja

Diabetes Asia Journal · 30.01.2026 · 2 (4) · 63-69

DOI: 10.62996/daj.77052025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Asia Journal, online erschienen am 30.01.2026. Verfasst von Shweta Verma und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study examines how Medical Nutrition Therapy (MNT) and Metformin help manage early gestational glucose intolerance during the 8th-10th weeks of pregnancy, especially when postprandial blood glucose (PPBG) is>110 mg/dL. The goal is to find out if these treatments can prevent gestational diabetes mellitus (GDM) and lower the risk of diabetes after pregnancy. Material and Methods A prospective cohort study was conducted at GSVM Medical Hospital in Kanpur, involving approximately 231 pregnant women at 8 to 10 weeks of gestation with pre-prandial blood glucose (PPBG) levels of at least 110 mg/dL. Participants were randomly assigned to either the MNT-Metformin group, receiving dosages ranging from 500 to 2500 mg, or the MNT-only group.

Results

At 2 to 3 days postpartum and at 6 weeks, the mean PPBG for the Metformin plus MNT group was 106.9 ± 5.24 mg/dL and 107.51 ± 10.67 mg/dL, respectively (P = 0.57). The mean HBA1c values were 4.84 ± 0.20 and 4.99 ± 0.37, respectively, with a P-value < 0.05.

Conclusion

Early detection and management of early gestational glucose intolerance (EGGI) with medical nutrition therapy (MNT) and Metformin can prevent progression to diabetes risk during postpartum screening. Keywords: EGGI Early gestational glucose intolerance, Gestational diabetes mellitus (GDM), PPBG Postprandial blood glucose, MNT Medical Nutrition Therapy, OGCT Oral Glucose challenge Test, DIPSI diabetes in Pregnancy Study Group India.

Zitieren

APA

Verma, S., Gupta, R., Gupta, N., Dwivedi, D., & Taneja, P. (2026). Medical Nutrition Therapy & Metformin in Early Gestational Glucose Intolerance to Prevent Post-Partum Diabetes Risk in a hospital Prospective Study. Diabetes Asia Journal, 2(4), 63-69. https://doi.org/10.62996/daj.77052025

Vancouver

Verma S, Gupta R, Gupta N, Dwivedi D, Taneja P. Medical Nutrition Therapy & Metformin in Early Gestational Glucose Intolerance to Prevent Post-Partum Diabetes Risk in a hospital Prospective Study. Diabetes Asia Journal. 2026;2(4):63-69. doi:10.62996/daj.77052025

BibTeX
@article{Verma2026,
  author = {Verma, Shweta and Gupta, Renu and Gupta, Neena and Dwivedi, Divya and Taneja, Palak},
  title = {Medical Nutrition Therapy & Metformin in Early Gestational Glucose Intolerance to Prevent Post-Partum Diabetes Risk in a hospital Prospective Study},
  journal = {Diabetes Asia Journal},
  year = {2026},
  volume = {2},
  number = {4},
  pages = {63--69},
  doi = {10.62996/daj.77052025}
}
Kostenlos starten →